Summit Hotel Properties, Inc. (INN)
Chart Events
Performance Outlook
| Previous Close | 7.27 |
| Open | 7.22 |
| Bid | 7.09 x 1000 |
| Ask | 7.10 x 900 |
| Day's Range | 7.04 - 7.22 |
| 52 Week Range | 6.70 - 10.94 |
| Volume | |
| Avg. Volume | 961,359 |
| Market Cap | 749.415M |
| Beta (5Y Monthly) | 2.21 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.11 |
| Earnings Date | Feb 21, 2022 - Feb 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Feb 13, 2020 |
| 1y Target Est | 12.33 |
- Zacks
Summit Hotel Properties (INN) Moves 7.9% Higher: Will This Strength Last?
Summit Hotel Properties (INN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Newsfile
Innocan Reports Successful Preclinical Dog-Trial Results Regarding Pain Management: "It Was as If a New Dog Came into Our Lives"
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 24, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce successful preclinical trials in dogs with osteoarthritis. A case entailing the clinical condition of Goody, an 8-year-old male mixed-breed dog, who was rescued in a terrible condition after he was found tied up with a very short leash, cachectic and wounded, was published. Goody suffers from ...
- Newsfile
Innocan Pharma Announces Filing of PCT Patent Application for Vaginal Atrophy Treatment
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - June 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") is pleased to announce that it has filed a new PCT patent application entitled "Compositions for Treatment of Vaginal Atrophy" on June 12, 2022, claiming priority from a US provisional patent. Vaginal atrophy is a condition associated with loss of moisture, thinning, and inflammation of the vaginal walls, which can ...
